PI: Gene D. Morse, PharmD
Dr. Gene D. Morse has been conducting antiretroviral pharmacology research since the beginning of the HIV epidemic. In 1986, Dr. Morse developed the Laboratory for Antiretroviral Research at the University at Buffalo in the School of Pharmacy and Pharmaceutical Sciences. The laboratory has been a training site for numerous post-doctoral fellows and residents as well as pre-doctoral students. The laboratory is approved by New York State to conduct protease inhibitor assays in support of therapeutic drug monitoring research for antiretrovirals.
Dr. Morse has developed HIV pharmacology clerkship training for clinical evaluation of antiretroviral therapy in acute care and ambulatory settings, established an HIV Certificate program, a post-doctoral pharmacy residency program and a post-doctoral fellowship program in HIV/AIDS pharmacology. Dr. Morse has mentored international fellows from Cairo and Harare and collaborated with Dr. Maponga on the development of the International Center for HIV/AIDS Pharmacotherapy Research and Training (ICHAPRT). Dr. Morse has served as a grant reviewer for the National Institutes of Health, The Ontario HIV Research Council and the Netherlands HIV/AIDS Research Council. Dr. Morse established the HIV ePharmacotherapy Network (http://www.hiv.buffalo.edu/) an international website to foster education, research and technology transfer in HIV/AIDS pharmacotherapy.
Co-PI: Chiedza C. Maponga, PharmD
Dr. Maponga is a Senior Lecturer and Director of the School of Pharmacy in the University of Zimbabwe’s College of Health Sciences. He also holds a visiting faculty position at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. This position requires him to rotate 3 to 4 times annually between the USA and Zimbabwe while coordinating the activities of a collaborative program called the International Pharmacotherapy Education and Research Initiative (IPERI). In April 2009, this program was awarded the Fogarty AIDS International Training and Research Program (AITRP) grant (grant no. 1D43TW007991-01A2) to implement a postgraduate training initiative with an emphasis on HIV/AIDS clinical pharmacology between the University at Buffalo (UB) and the University of Zimbabwe (UZ).
The UB-UZ HRTP Program is proud to introduce our team: